GSK (NYSE:GSK) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.27 by 6.3 percent. This is a 8.87 percent increase over earnings of $1.24 per share from the same period last year. The company reported quarterly sales of $11.280 billion which beat the analyst consensus estimate of $10.790 billion by 4.54 percent. This is a 5.82 percent increase over sales of $10.660 billion the same period last year.